T lymphocytes in pleural effusion

Chinese Medical Journal

Volumn 121, Issue 7, 2008, Pages 579-580

  Yang, Hai Bo ^a   Shi, Huan Zhong ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 16; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

B LYMPHOCYTE; BACTERIAL IMMUNITY; BLOOD VESSEL PERMEABILITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EDITORIAL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG CANCER; LUNG SURGERY; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; PLEURA EFFUSION; PLEURISY; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULOUS PLEURISY; TUMOR IMMUNITY; IMMUNOLOGY; PHYSIOLOGY;

HUMANS; PLEURAL EFFUSION; T-LYMPHOCYTES, REGULATORY;

EID: 46449092280     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200804010-00001     Document Type: Editorial

References (16)

1. Light RW. Clinical practice. Pleural effusion. N Engl J Med 2002; 346: 1971-1977.
2. Dalbeth N, Lee YC. Lymphocytes in pleural disease. Curr Opin Pulm Med 2005; 11: 334-339.
3. Noppen M, De Waele M, Li R, Gucht KV, D'Haese J, Gerlo E, et al. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 2000; 162: 1023-1026.
4. Pettersson T, Klockars M, Hellstrom PE, Riska H, Wangel A. T and B lymphocytes in pleural effusions. Chest 1978; 73: 49-51.
5. + T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989; 142: 1114-1119.
6. Lucivero G, Pierucci G, Bonomo L. Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J 1988; 1: 337-340.
7. Takahashi K. Sone S. Kimura S. Ogura T. Monden Y. Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion. Chest 1993; 103: 1732-1738.
8. + lymphocytes in pleural cavity of patients with non-small cell lung cancer. Thorax 2001; 56: 639-642.
9. Terabe M, Berzofsky JA. Immunoregulatory T cells in tumor immunity. Curr Opin Immunol 2004; 16: 157-162.
10. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
11. + regulatory T lymphocytes in allergy and asthma. Allergy 2005; 60: 986-995.
12. + egulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med 2005; 172: 1434-1439.
13. + regulatory T lymphocytes in tuberculous pleural effusion. Chin Med J 2008; 121: 581-586.
14. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J Immunol 2004; 172: 5213-5221.
15. Curiel TJ, Coukos G, Zen L, Alvarez X, Cheng P, Mottrain P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.
16. Qin XJ, Shi HZ, Huang ZX, Kang LF, Mo WN, Wu C. Interleukin-16 tuberculous and malignant pleural effusions. Eur Respir J 2005; 25: 605-611.